UB Paderborn / Katalog / Suche / in CDI

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Journal of hematology and oncology, 2018-12, Vol.11 (1), p.141-141, Article 141

2018

Link zum Volltext

Verfügbarkeit prüfen

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Journal of hematology and oncology, 2022-07, Vol.15 (1), p.1-86, Article 86

2022

Link zum Volltext

Verfügbarkeit prüfen

Neuronal Nitric Oxide Synthase Regulates Depression-like Behaviors in Shortening-Induced Obese Mice

Nutrients, 2022-10, Vol.14 (20), p.4302

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial

Journal of hematology and oncology, 2024-04, Vol.17 (1), p.23-23, Article 23

2024

Link zum Volltext

Verfügbarkeit prüfen

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Journal of medical case reports, 2022-12, Vol.16 (1), p.459-459, Article 459

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel neuroprotectant chiral 3-n-butylphthalide inhibits tandem-pore-domain potassium channel TREK-1

Acta pharmacologica Sinica, 2011-02, Vol.32 (2), p.182-187

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of Thalidomide on Peripheral Blood Th17 Cells of Patients with Multiple Myeloma

Zhongguo shi yan xue ye xue za zhi, 2015-10, Vol.23 (5), p.1341

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic effects of porcine versus rabbit antithymocyte globulins for treatment of severe aplastic anemia

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2016-03, Vol.36 (3), p.303

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characteristics,Treatment Strategies and Prognostic Factors of 254 Cases of Non Hodgkin's Lymphoma

Zhongguo shi yan xue ye xue za zhi, 2016-08, Vol.24 (4), p.1044

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Study of Non Hodgkin's Lymphoma Treated with Enhanced Chemotherapy Regimen and Increased Treatment Courses

Zhongguo shi yan xue ye xue za zhi, 2015-12, Vol.23 (6), p.1612

2015

Link zum Volltext

Verfügbarkeit prüfen

Cohort Study on GHA and New Combined Priming Chemotherapeutic Regimens in Treatment of Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Zhongguo shi yan xue ye xue za zhi, 2015-04, Vol.23 (2), p.369

2015

Link zum Volltext

Verfügbarkeit prüfen

Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

American journal of hematology, 2008-03, Vol.83 (3), p.185-188

2008

Link zum Volltext

Verfügbarkeit prüfen

P874: LONG‐TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR‐B38M CAR‐T – AT LEAST 5‐YEAR FOLLOW‐UP IN LEGEND‐2

HemaSphere, 2023-08, Vol.7 (S3), p.e9841889-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of granulocyte colony-stimulating factor Priming Combined with Low-dose cytarabine and homoharringtonine in Higher Risk myelodysplastic syndrome Patients

Leukemia research, 2016-09, Vol.48, p.57-61

2016

Link zum Volltext

Verfügbarkeit prüfen

Agriculture financial support for the development of agricultural economy in china taiwan : research on the credit department of farmers' association

Zhao, Wan Hong

2010

Link zum Volltext

Verfügbarkeit prüfen

Anti-tumor effect of two adjuvants of CpG ODN on leukemic tumor in mouse models

Zhongguo shi yan xue ye xue za zhi, 2007-10, Vol.15 (5), p.1042

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of G-CSF on induction of ENA-78 and IL-8 in the patients with malignant lymphoma

Zhongguo shi yan xue ye xue za zhi, 2014-04, Vol.22 (2), p.344

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunological screening for multiple myeloma-associated antigens and their bioinformatics analysis

Zhongguo shi yan xue ye xue za zhi, 2006-04, Vol.14 (2), p.252

2006

Link zum Volltext

Verfügbarkeit prüfen

Retrospective observation of curative effects on MDS refractory anemia with combination of all-trans retinoic acid, 1, 25-dihydroxyvitamin D3 and androgen

Zhongguo shi yan xue ye xue za zhi, 2005-10, Vol.13 (5), p.861

2005

Link zum Volltext

Verfügbarkeit prüfen

Intracortical microstimulation parameters modulate flight behavior in pigeon

Journal of integrative neuroscience, 2019-03, Vol.18 (1), p.23-32

2019

Link zum Volltext

Verfügbarkeit prüfen

Construction and significance of directional expression cDNA library from myeloid leukemia cell line U937

Zhongguo shi yan xue ye xue za zhi, 2003-08, Vol.11 (4), p.355

2003

Link zum Volltext

Verfügbarkeit prüfen

Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura

Acta pharmacologica Sinica, 2005-05, Vol.26 (5), p.598-602

2005

Link zum Volltext

Verfügbarkeit prüfen

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment of LCAR-B38M CAR-T: At least 5-year follow-up in LEGEND-2

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8010-8010

2023

Link zum Volltext

Verfügbarkeit prüfen

Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan

Zhongguo shi yan xue ye xue za zhi, 2007-06, Vol.15 (3), p.478

2007

Link zum Volltext

Verfügbarkeit prüfen

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease–a Single Institution Observation in China

Blood, 2020-11, Vol.136 (Supplement 1), p.6-6

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Neuronal Nitric Oxide Synthase Regulates Depression-like Behaviors in Shortening-Induced Obese Mice

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Novel neuroprotectant chiral 3-n-butylphthalide inhibits tandem-pore-domain potassium channel TREK-1

Effects of Thalidomide on Peripheral Blood Th17 Cells of Patients with Multiple Myeloma

Therapeutic effects of porcine versus rabbit antithymocyte globulins for treatment of severe aplastic anemia

Clinical Characteristics,Treatment Strategies and Prognostic Factors of 254 Cases of Non Hodgkin's Lymphoma

Clinical Study of Non Hodgkin's Lymphoma Treated with Enhanced Chemotherapy Regimen and Increased Treatment Courses

Cohort Study on GHA and New Combined Priming Chemotherapeutic Regimens in Treatment of Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

P874: LONG‐TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR‐B38M CAR‐T – AT LEAST 5‐YEAR FOLLOW‐UP IN LEGEND‐2

Effect of granulocyte colony-stimulating factor Priming Combined with Low-dose cytarabine and homoharringtonine in Higher Risk myelodysplastic syndrome Patients

Agriculture financial support for the development of agricultural economy in china taiwan : research on the credit department of farmers' association

Anti-tumor effect of two adjuvants of CpG ODN on leukemic tumor in mouse models

Effect of G-CSF on induction of ENA-78 and IL-8 in the patients with malignant lymphoma

Immunological screening for multiple myeloma-associated antigens and their bioinformatics analysis

Retrospective observation of curative effects on MDS refractory anemia with combination of all-trans retinoic acid, 1, 25-dihydroxyvitamin D3 and androgen

Intracortical microstimulation parameters modulate flight behavior in pigeon

Construction and significance of directional expression cDNA library from myeloid leukemia cell line U937

Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment of LCAR-B38M CAR-T: At least 5-year follow-up in LEGEND-2

Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease–a Single Institution Observation in China

Suchergebnisse filtern